Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models. Rev Diabet Stud [Internet]. 2025 Sep. 10 [cited 2025 Sep. 24];:1-21. Available from: https://www.diabeticstudies.org/index.php/RDS/article/view/493